Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Resource Type
Article
Authors
Qin, Shukui ; Li, Qiu ; Gu, Shanzhi ; Chen, Xiaoming ; Lin, Lizhu ; Wang, Zishu ; Xu, Aibing ; Chen, Xi ; Zhou, Cuncai ; Ren, Zhenggang ; Yang, Lin ; Xu, Li ; Bai, Yuxian ; Chen, Lei ; Li, Jun ; Pan, Hongming ; Cao, Bangwei ; Fang, Weijia ; Wu, Wei ; Wang, Ge ; Cheng, Ying ; Yu, Zhuang ; Zhu, Xu ; Jiang, Da ; Lu, Yinying ; Wang, Huaming ; Xu, Jianming ; Bai, Li ; Liu, Yunpeng ; Lin, Hailan ; Wu, Changping ; Zhang, Yang ; Yan, Ping ; Jin, Chunlei ; Zou, Jianjun
Source
In The Lancet Gastroenterology & Hepatology July 2021 6(7):559-568
Subject
Primary Research Articles
Language
ISSN
2468-1253